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Introduction: It is still unknown how best to maintain effects of exercise programmes in COPD
in the long-term. We present the long-term effects of a community-based exercise programme
incorporated in a self-management programme, compared to a self-management programme
only in patients with COPD.
Methods: All included patients participated in four self-management sessions. Additionally,
patients in the intervention group participated in an 11-month community-based exercise pro-
gramme led by physiotherapists. Patients trained three times/week for six months and two
times/week during the subsequent five months. To encourage a behavioural change towards
exercise, one of these weekly training sessions was home-based (unsupervised). No formal ex-
ercise training was offered to intervention patients in the second year.
Results: The intervention was assigned to 80 patients, and the control condition to 79 patients.
82.5% and 78.5% of the intervention and control group, respectively, completed 24 months
follow-up. Modified intention-to-treat analyses were performed. Although statistically signifi-
cant after 12 months (35.1 m (95%CI: 8.4e61.8)), the between-group difference on maximal
exercise capacity was not statistically significant after 24 months (12.2 m (95%CI: 16.6 to4873013; fax: þ31 534872676.
(M.Zwerink).
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1482 M. Zwerink et al.41.0). Nevertheless, the between-group difference in daily physical activity was maintained
after 24 months (1193 steps/day (95%CI: 203e2182)). A beneficial effect was also found on
CRQ dyspnoea score but not on other CRQ domains, CCQ and HADS.
Conclusions: Our intervention was effective in achieving a behavioural change reflected by a
sustained increase in daily physical activity, not accompanied by a sustained increase in
maximal exercise capacity after two years of follow-up (ISRCTN81447311).
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is not only
characterized by symptoms of dyspnoea, chronic cough,
and sputum production, but also and importantly by
decreased exercise capacity [1] and a reduced physical
activity level [2e4]. A large number of randomised
controlled trials have investigated the effects of exercise
training programmes, whether part of a formal pulmonary
rehabilitation programme or not, on exercise capacity in
patients with COPD. A meta-analysis of Lacasse et al. [5]
included 31 randomised trials, and found that rehabili-
tation programmes including exercise therapy are effec-
tive in improving exercise capacity and quality of life.
However, in this review only short-term effects (i.e. ef-
fects directly after the end of the intervention) were
assessed. The results on the longer term are less unani-
mous [6e9].
It is increasingly recognised that the long-term mainte-
nance of beneficial effects of exercise programmes in pa-
tients with COPD is problematic [1,10,11]. The leading
hypothesis in this discussion is that one should not solely
aim at the improvement of exercise capacity but also at a
behavioural change towards exercise and physical activity
[1,10,11]. Self-management training can play an important
role in this context and is increasingly offered to patients
with COPD, regularly combined with exercise programmes
[1]. The goal of self-management is to teach patients the
skills they need to carry out disease specific medical regi-
mens, and to guide behaviour change to help patients
control their own condition and improve their wellbeing
[12,13]. Although self-management training is effective in
improving quality of life and reducing respiratory-related
hospitalisations, it remains unclear which components
contribute most to its effectiveness [14].
The COPE-II study is a randomised controlled trial that
evaluated the effects of a community-based physiother-
apeutic exercise programme (COPE-active) within a self-
management programme [15]. One of the main goals of
the COPE-active programme was to achieve a behaviour
change towards exercise in daily life. A relatively long
training period of 11 months was chosen to facilitate the
change from training under supervision of a physiothera-
pist to unsupervised exercise at home. To support this
further, one training session was home-based and unsu-
pervised during the entire training period. After one year
of follow-up, patients who participated in the COPE-active
programme showed an improved maximal exercise capac-
ity and a positive change in daily physical activity incomparison with the control group [15]. On the short term,
directly after the end of the structured exercise pro-
gramme, the goal of behavioural change was therefore
achieved. The current paper reports the long-term effects
of the COPE-active programme on exercise capacity and
daily physical activity in patients with COPD, i.e. after two
years of follow-up.Methods
Study design
The detailed study design was published earlier [15,16]. In
the COPE-II study a 2  2 factorial design was used. This
means that two independent interventions, a community-
based exercise programme and self-treatment of exacer-
bations, were evaluated in one design. In this report, the
effectiveness at two years follow-up of a community-based
exercise programme incorporated in a self-management
programme was compared to the effectiveness of a self-
management programme only. Both treatment regimens
were allocated using a minimisation programme [17], and
patients receiving guidelines for self-treatment were
equally distributed over the COPE-active programme and
the control group. Patients were assessed at baseline, after
7, 12, 18 and 24 months.Patients
From November 2004 through July 2006, participants were
recruited from the outpatient department of pulmonary
medicine [15]. Patients eligible for inclusion had a clinical
diagnosis of COPD according to the GOLD criteria [18]; a
post-bronchodilator FEV1 between 25 and 80% of pre-
dicted; additionally, they had to have had at least three
exacerbations or one hospitalisation for respiratory prob-
lems in the two years preceding study entry. Patients were
excluded when they had a serious other disease with a low
survival rate; another disease that influenced bronchial
symptoms and/or lung function; a need for regular oxygen
therapy; a disorder or progressive disease that seriously
influenced walking ability. The study protocol was
approved by the medicaleethical review committee of
Medisch Spectrum Twente hospital and written informed
consent was obtained from all participants [15]. The COPE-
II study was registered in the ISRCTN register
(ISRCTN81447311).
Community-based exercise in COPD self-management 1483Self-management sessions and COPE-active
programme
All patients participated in four weekly 2-h small-group
(approximately 5 patients) self-management sessions led by
a respiratory nurse and a physiotherapist. The goal of the
course was to change the patients’ disease behaviour by
increasing their knowledge, confronting them with conse-
quences of specific behaviour, and supplying them with
tools to deal with different components of their disease.
The respiratory nurse contacted all patients by telephone
4, 13 and 26 weeks after the last course to recall the items
addressed during the self-management courses. Patients
were supplied with a booklet with the content of the
courses [15].
Only patients in the intervention group participated in
a community-based physiotherapeutic exercise pro-
gramme (COPE-active), of which details were published
earlier [15]. The COPE-active programme was divided in
two parts: a ‘compulsory’ 6-month, and a subsequent
optional but recommended 5-month training period. In
the first period, patients trained three times per week,
and in the second period patients trained two times per
week. In both periods, one of these weekly training ses-
sions was performed at home to encourage the patients
to exercise in their own environment. The training ses-
sions consisted of cycling, walking, climbing stairs, and
lifting weights. Besides improvement of physical condi-
tion, the main goal of COPE-active was a behaviour
change towards exercise. The intensity of the programme
was tailored to the individual patient’s performance level
by providing the physiotherapist with the baseline results
of the cardio-pulmonary exercise test, and the incre-
mental shuttle walk test. After the 11-month supervised
training period, patients in the COPE-active group were
advised to continue the unsupervised training at home,
but not to follow any formal physiotherapeutic exercise
training programme. Instead, the patients were encour-
aged to participate in other forms of community-based
exercise.Table 1 Baseline characteristics.
COPE-active Control
Number of patients 77 76
Age (years) 63.1  8.1 64.1  7.7
Gender (%male) 58.4% 57.9%
Body mass index (kg/m2) 26.1  5.0 26.8  4.4
Smokers 35% 34%
Medical Research Council
dyspnoea scale
2.25  1.05 2.50  1.15
FEV1 (L) 1.43  0.54 1.40  0.53
FEV1 (% of predicted) 49.6  14.2 50.5  17.0
VC (L) 3.78  1.05 3.47  0.84
Data are presented as mean  standard deviation (sd) unless
otherwise stated.Outcome measures
The primary outcome was maximal exercise capacity
measured with the incremental shuttle walk test (ISWT)
according to the protocol of Singh et al. [19] using a 10-m
course. A practice walk was performed before the base-
line measurement. According to current standard, an indi-
vidual change of at least 47.5 m is considered clinically
important [20]. Endurance capacity was measured with the
endurance shuttle walk test (ESWT) using a 10-m course and
a walking speed of 85% of the maximal ISWT walking speed
[21]. Daily physical activity was assessed by the number of
steps measured with a pedometer (Yamax Digi-Walker SW-
200; Tokyo, Japan) during a 7-day period. HRQoL was
measured by the self-administered standardised Chronic
Respiratory Disease Questionnaire (CRQ-SAS) [22]. An indi-
vidual change of at least 0.5/domain (dyspnoea, fatigue,
emotional functioning, mastery) is considered clinically
important [23]. Health status was evaluated by the self-
administrated Clinical COPD Questionnaire (CCQ) [24]. Achange of 0.4 is considered to represent a minimal impor-
tant difference at the individual level [25]. Anxiety and
depression were measured with the Hospital Anxiety and
Depression Scale (HADS) [26]. This instrument produces
separate scores for anxiety and depression ranging from
0 to 21.
Statistical analysis
Between-group differences in continuous variables over
time were assessed by analysis of repeated measurements
with fixed effects (SPSS procedure for mixed models,
version 20). Baseline values were subtracted from follow-up
values to correct for baseline differences. A modified
intention-to-treat approach was used for all primary ana-
lyses, meaning that all patients who completed at least the
baseline measurement were included in the analyses. Sec-
ondary, a per protocol analysis was performed on the pri-
mary outcome, maximal exercise capacity, in order to
assess the effects of the programme in patients who
adhered to the exercise programme. Adherence was
defined as participation in at least 70% of the sessions.
The one year effects as presented in the text of the
results section were obtained from the one year analyses as
published earlier [15]. These values deviate from the one
year values in the current two year analysis as presented in
Tables 2 and 4. Due to the additional data collected in the
second year of follow-up, estimations of missing values are
slightly different in the first year compared to the second
year, resulting in slightly different outcomes.
Results
Patients and follow-up
The intervention (community-based exercise programme)
was assigned to 80 of the 159 included patients, while the
control condition was assigned to 79 of them (Fig. 1). After
one year of follow-up, 74 (92.5%) patients in the interven-
tion group 68 (86.1%) patients in the control group still
participated. In the second year of follow-up, an additional
eight patients in the intervention group and six patients in
the control group were lost-to-follow up, resulting in 66
(82.5%) and 62 (78.5%) patients, respectively, completing
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1484 M. Zwerink et al.the two years follow-up (Fig. 1). Reasons for drop out
were comparable between the groups (Fig. 1). Six pa-
tients dropped out before the baseline measurements, so
baseline characteristics of 153 patients are presented in
Table 1.
Exercise capacity
Maximal exercise capacity was measured with the ISWT.
After one year of follow-up, directly after the end of the
supervised exercise programme, there was a statistically
significant between-group difference in mean change
from baseline in walking distance of 35.1 m (95%CI:
8.4e61.8). After two years of follow-up the between-
group difference in mean change from baseline in
walking distance was reduced to 12.2 m (95%CI:
16.6e41.0) (Fig. 2A), with better performance in the
COPE-active group, but no longer statistically significant
(Table 2).
Endurance capacity was measured with the ESWT.
After one year of follow up, the between-group differ-
ence in mean change from baseline in walking distance
was 145.8 m (95%CI: 26.2 to 317.8) in favour of the
intervention group, but not statistically significant. After
two years this difference was reduced to 52.1 m (95%CI:
145.6 to 249.8) (Table 2).
Daily physical activity
Daily physical activity was measured with a pedometer.
The change from baseline in mean number of steps per
day was calculated over a 7-day period. After one year of
follow-up, there was a statistically significant between-
group difference in mean change from baseline in num-
ber of steps/day of 1190.4 (95%CI: 255.6e2125.2) in
favour of the COPE-active group. After two years of
follow-up this between-group difference was main-
tained, and still statistically significant, with 1193 steps/
day (95%CI: 203e2183) (Fig. 3 and Table 2).
Pedometer data at 24 months were missing in 26 (34%)
patients in both groups (28 due to drop-out, and 24 due to
other reasons). We assessed whether patients who had
not completed the pedometer measurement at 24
months of follow-up were different with regard to base-
line characteristics from patients who had completed the
measurement. Patients with a missing pedometer mea-
surement at 24 months follow-up were in a worse func-
tional state at baseline than patients who had a
pedometer measurement at that point of time (Table 3).
The degree in which this influenced total group means
was comparable in both groups and ranged from 0% to 8%.
Health status
As reported after one year, no between-group differ-
ences in mean scores were found in any domain of the
CCQ or the domains of fatigue, emotional function and
mastery of the CRQ after two years. The CRQ domain of
dyspnoea showed a between-group difference in mean
score of 0.30 points (95%CI: 0.14 to 0.74) after two
years of follow-up, which was comparable to the
Table 3 Baseline characteristics of patients with and without a pedometer measurement at 24 months follow-up.
COPE-active group Control group
With Without With Without
Nr of patients 51 25 50 25
Age (years) 63.2  7.6 63.1  9.3 63.9  7.5 64.4  8.5
Nr of patients 51 25 50 25
FEV1 (L) 1.49  0.53 1.29  0.56 1.43  0.51 1.35  0.57
Nr of patients 51 26 50 26
FEV1 (% of predicted) 50.1  13.2 48.5  16.3 50.6  15.9 50.3  19.4
Nr of patients 51 25 50 25
VC (L) 3.9  1.1 3.5  1.0 3.6  0.8 3.2  0.8
Nr of patients 51 26 48 26
ISWT 408.6  166 346.5  156.5 380.2  142.2 269.62  146.8
Nr of patients 51 26 48 26
ESWT 709.8  565.6 618.2  533.2 764.7  612.8 379.8  300.9
Nr of patients 47 15 47 18
Pedometer 4768  2831 3547  2141 5599  3764 4244  2329
Data are presented as mean  standard deviation (sd). ISWT: incremental shuttle walk test; ESWT: endurance shuttle walk test.
Community-based exercise in COPD self-management 1485difference after one year (0.32 points (95%CI: 0.03 to
0.67)). The overall difference over two years between the
intervention and control group was statistically significant
(0.35 (95%CI: 0.03e0.67)) but did not reach the minimal
important difference of 0.5. Anxiety and depression were
assessed with the HADS. There were no statistically signif-
icant differences in both these domains (Table 4).
Per protocol analysis ISWT
In our secondary per protocol analysis on the ISWT, we pre-
defined patients who participated in at least 70% of the
physiotherapy sessions as treated per protocol, i.e. as pa-
tients who sufficiently adhered to the programme. This was
the case in 67.5% of the patients. These patients who
adhered well, increased their mean walking distance with
24.9 m (95%CI: 2.0 to 51.8) after 12 months of follow-up
as compared to 11.1 m (95%CI: 10.0 to 32.2) in the group
also including the poor adherers. After two years of follow-
up, the loss in exercise capacity in the group with solely
adherers was smaller than in the total group (18.4 (95%CI:
42.4 to 5.7) vs. 30.4 (95%CI: 50.4 to 10.3) meters
compared to baseline). The overall between-group differ-
ence of 34.1 m (95%CI: 5.9e62.3) over 24 months was, in
contrast to that in the intention-to-treat analysis, still
statistically significant but did not reach the minimal clin-
ically important difference of 35.1 m (Fig. 2B).Discussion
The goal of this study was to compare the long-term effects
of a community-based exercise programme incorporated in
a self-management programme with the effects of a self-
management programme only in patients with COPD.
Maximal exercise capacity as measured with the ISWT was
substantially better in the intervention group compared to
the control group after one year of follow-up, but this
initial increase was not maintained in the second year offollow-up. As a consequence, the overall benefit measured
over two years was not statistically significantly different
between the two groups. In contrast with this, the benefi-
cial effect on daily physical activity was maintained after
two years. After 24 months, the intervention still had a
positive effect on the CRQ dyspnoea domain, but no sta-
tistically significant effects were seen on the other CRQ
domains, the CCQ, the HADS, and the ESWT.
Only a few studies have used the ISWT to address long-
term effects of exercise programmes, mainly classified as
pulmonary rehabilitation, on exercise capacity in patients
with COPD. Two of these studies, with intervention periods
of six and eight weeks, found a decline in ISWT walking
distance in the year following the initial intervention period
in the intervention group, but also a more gradual decline
in exercise capacity in the control group during the entire
period of follow-up [8,9]. As a result, differences in walking
distance between the intervention and the control group
were still statistically significant after one year of follow-up
[8]. Two other studies on long-term effects of exercise in
patients with COPD measured exercise capacity with the six
minute walking test (6MWT) [6,7]. Duration of the in-
terventions in these studies was more comparable to that
of our intervention, namely six and 12 months. Beneficial
effects of these programmes on 6MWT distance were
maintained after 18 and 24 months follow-up, respectively.
The results of studies assessing long-term maintenance of
exercise capacity after an exercise programme are there-
fore ambiguous.
The loss in exercise capacity in the second year of
follow-up in our study is probably due to a combination of
the discontinuation of regular exercise training and the
progressive character of COPD. Patients in this study suf-
fered from relatively severe disease with relatively
frequent exacerbations, and it is known that each exacer-
bation negatively influences the functional state of the
patient [27]. Patients were encouraged to participate in
some sort of community-based exercise (e.g. general or
respiratory specific exercise programmes not reimbursed as
Table 4 Baseline scores and mean differences from baseline at 12, 18 and 24 months of health status in the COPE-active and control group.
Difference from baselinea Between-group difference
Baseline 12 months 18 months 24 months D 24 months D Overalla
Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95%CI) Mean (95%CI)
CRQ-I Nr of patients 77 71 68 65
Dyspnoea 4.40 (4.08; 4.73) 0.30 (0.06; 0.54) 0.24 (0.04; 0.52) 0.08 (0.24; 0.39) 0.30 (0.14; 0.74) 0.35 (0.03; 0.67)
Fatigue 4.55 (4.27; 4.83) 0.14 (0.16; 0.43) 0.09 (0.21; 0.39) 0.07 (0.38; 0.23) 0.02 (0.45; 0.42) 0.08 (0.27; 0.43)
Emotional function 5.14 (4.88; 5.41) 0.18 (0.04; 0.4) 0.04 (0.19; 0.26) 0.27 (0.05; 0.50) 0.23 (0.10; 0.55) 0.12 (0.12; 0.37)
Mastery 5.35 (5.09; 5.61) 0.33 (0.08; 0.57) 0.14 (0.11; 0.39) 0.13 (0.12; 0.38) 0.25 (0.11; 0.61) 0.16 (0.13; 0.45)
CRQ-C Nr of patients 76 68 63 60
Dyspnoea 4.52 (4.21; 4.84) 0.01 (0.26; 0.23) 0.19 (0.48; 0.1) 0.22 (0.54; 0.1)
Fatigue 4.13 (3.84; 4.42) 0.06 (0.24; 0.36) 0.07 (0.38; 0.24) 0.06 (0.37; 0.26)
Emotional function 4.90 (4.67; 5.13) 0.09 (0.14; 0.31) 0.11 (0.34; 0.12) 0.05 (0.19; 0.28)
Mastery 5.30 (5.05; 5.55) 0.23 (0.02; 0.47) 0.03 (0.29; 0.22) 0.12 (0.38; 0.14)
CCQ-I Nr of patients 77 70 68 65
Symptoms 2.5 (2.12; 2.58) 0.10 (0.36; 0.15) 0.06 (0.29; 0.17) 0.03 (0.24; 0.29) 0.30 (0.07; 0.68) 0.14 (0.15; 0.43)
Functional state 2.14 (1.87; 2.41) 0.05 (0.29; 0.20) 0.20 (0.05; 0.45) 0.21 (0.05; 0.46) 0.14 (0.22; 0.51) 0.04 (0.27; 0.34)
Mental state 0.93 (0.71; 1.15) 0.13 (0.36; 0.10) 0.12 (0.37; 0.14) 0.02 (0.27; 0.30) 0 (0.40; 0.41) 0.05 (0.37; 0.26)
Total 1.81 (1.60; 2.01) 0.10 (0.28; 0.09) 0.01 (0.18; 0.19) 0.09 (0.10; 0.27) 0.16 (0.11; 0.43) 0.04 (0.18; 0.27)
CCQ-C Nr of patients 74 66 61 58
Symptoms 2.92 (2.64; 3.21) 0.17 (0.43; 0.09) 0.29 (0.53; 0.03) 0.28 (0.55; 0.00)
Functional state 2.33 (2.03; 2.63) 0.05 (0.20; 0.31) 0.13 (0.13; 0.39) 0.06 (0.20; 0.33)
Mental state 1.03 (0.77; 1.28) 0.11 (0.35; 0.12) 0.06 (0.33; 0.20) 0.02 (0.28; 0.31)
Total 2.09 (1.87; 2.31) 0.08 (0.27; 0.11) 0.07 (0.27; 0.12) 0.07 (0.27; 0.13)
HADS-I Nr of patients 76 69 67 63
Anxiety 4.26 (3.41; 5.12) 0.69 (1.37; 0.01) 0.39 (0.41; 1.19) 0.24 (0.99; 0.51) 0.18 (1.24; 0.89) 0.09 (0.69; 0.88)
Depression 3.96 (3.12; 4.80) 0.72 (1.32; 0.11) 0.20 (0.56; 0.96) 0.28 (1.0; 0.44) 0.26 (1.27; 0.75) 0.27 (1.00; 0.51)
HADS-C Nr of patients 76 68 63 60
Anxiety 5.38 (4.56; 6.21) 0.59 (1.3; 0.10) 0.10 (0.92; 0.72) 0.07 (0.83; 0.70)
Depression 5.24 (4.35; 6.12) 0.30 (0.91; 0.31) 0.76 (0.02; 1.54) 0.02 (0.75; 0.72)
I: COPE-active group; C: control group; CRQ: Chronic Respiratory Disease Questionnaire; CCQ: Clinical COPD Questionnaire; HADS: Hospital Anxiety and Depression Scale.
a Intention to treat analysis. Results were obtained with repeated measurements analysis.
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Figure 1 Patient flow during 24 months follow-up.
Community-based exercise in COPD self-management 1487physiotherapy) at the end of the formal community-based
exercise programme. However, the decrease in exercise
capacity in the second year of follow-up suggests that most
have failed to attend such programmes, or otherwise that
training intensity and frequency of these programmes have
been insufficient to maintain the gain in exercise capacity.
Proper maintenance programmes might be preventing loss
of beneficial effects after the initial exercise programme.
In a systematic review of Beauchamp et al. regarding the
effectiveness of supervised exercise programmes after an
initial pulmonary rehabilitation programme in patients with
COPD [10] only six studies could be included, and their
meta-analysis showed a beneficial effect on 6MWT walking
distance after six months, but after 12 months follow-up,
differences between study groups were no longer statisti-
cally significant [10]. This indicates that even formal (ex-
ercise) programmes after the end of the initial programme
are no guarantee for maintenance of beneficial effects.
More research on the optimal maintenance programme
after a primary exercise programme is therefore needed.
A crucial factor in the success of exercise interventions
is adherence of patients to the programmes [28]. In our per
protocol analysis on the ISWTwe excluded 26 (34%) patients
who participated in less than 70% of the physiotherapeuticexercise sessions and were therefore classified as non-
adherent. Per protocol analyses should be interpreted
with extreme care since they most likely introduce selec-
tion bias. Our per protocol analysis suggests that patients
who adhered are doing better than patients who did not,
however non-adherent patients were worse at baseline
than adherent patients (data not shown). It therefore re-
mains to be seen whether this is an actual effect of the
intervention or a result of selection bias. The primary
intention to treat analysis gives probably the most realistic
look on the effectiveness of the intervention in real life,
since non-adherence is part of daily practice [29].
It is interesting to note that, although the improvement
in maximal exercise capacity at one year was not main-
tained over two years, improvement in daily physical ac-
tivity as measured with a pedometer, was maintained at
two years. Maximal exercise capacity is a measure of what
patients are able to do, and daily physical activity is a
measure of what patients actually do. So, these are two
different concepts [30]. It is known that an increase in
exercise capacity can already be achieved with an exercise
programme as short as four weeks [31], however changes in
behaviour are usually not achieved in a couple of weeks
[32,33]. Our data suggests that we not only achieved a
Figure 2 Mean change from baseline in incremental shuttle walk test (ISWT) walking distance over 24 months of follow-up using
an intention to treat analysis (A) and a per protocol analysis (B).
1488 M. Zwerink et al.change in activity behaviour, but that this effect was also
maintained after two years of follow-up. However, our data
also suggests that the intensity and/or frequency of this
additional daily physical activity has most certainly been
too low to actually contribute to maintenance of maximal
exercise capacity. We were not able to assess the fre-
quency and intensity of physical activity, since we used
basic pedometers. A study that did assess walking intensity
in patients with COPD concluded that 84% of the patients
reached more than 30 min of walking time per day but that
only less than a quarter of this time was walked at least
moderate intensity [34]. In another study [33,35,36] pa-
tients were classified as regular or irregular walkers, and
compared with regard to long-term maintenance of effectof a pulmonary rehabilitation programme. Both regular and
irregular walkers steadily declined in 6MWT distance during
24 months follow-up [36]. These findings seem to underline
that walking is not sufficient to maintain an initial increase
in exercise capacity.
We used pedometers to measure daily physical activity,
which can be seen as a limitation since nowadays more
sophisticated activity monitors are widely available, and
pedometers tend to underestimate step counts at slow
walking speed [37]. Also, we had a relatively large number
of missing data for daily physical activity. Despite great
efforts of the research personnel, there were issues with
pedometers that did not work (either due to low battery or
mechanical defects), patients not returning the pedometer
Figure 3 Mean change from baseline in daily physical activity (mean number of steps/day) over 24 months of follow-up using an
intention to treat analysis.
Community-based exercise in COPD self-management 1489and diary, or patients just not wearing the pedometer for
seven days. In general, patients who did not have a
pedometer measurement at 24 months follow-up seemed to
have a worse functional state at baseline compared to the
patients who had a measurement. Possible underestimation
due to the use of pedometers or overestimation due to the
relatively large amount of missing data would be expected
to be the same in both groups, and would therefore not
have affected the between-group difference.
A statistically significant between-group difference was
found on the CRQ-dyspnoea domain, indicating that pa-
tients who participated in the COPE-active programme
experienced less dyspnoea during activities than patients
in the control group [23]. Breathing exercises and coping
with breathlessness were part of the initial self-
management programme, but patients in the interven-
tion group had multiple opportunities to practice and
acquire these methods during exercise under supervision
of a physiotherapist. Also, improved exercise tolerance in
the intervention group might have led to a reduction in
exertional dyspnoea during activities which in turn might
have contributed to the increase in daily physical activity
[38]. As was expected based on the 12-month results, we
did not find any between-group differences on the other
CRQ domains or the CCQ. This is probably due to the
already relatively good scores at baseline which left little
room for improvement during follow up [15]. The same
accounts for anxiety and depression measured with the
HADS.
We had already shown that in comparison to a self-
management programme only, a community-based physi-
otherapeutic exercise programme was effective in
achieving a behavioural change reflected by an increase in
daily physical activity after one year. We now show that the
increase in daily physical activity could be maintained over
the second year, but not the increase in exercise capacity.We still need further studies investigating how an initial
increase in exercise capacity can be best maintained.Sources of funding
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